Imatinib - Dr Reddy's

New Zealand - English - Medsafe (Medicines Safety Authority)

Active ingredient:
Imatinib mesilate 119.47 mg equivalent to imatinib 100mg
Available from:
Dr Reddy's New Zealand Limited
INN (International Name):
Imatinib mesilate 119.47 mg (equivalent to imatinib 100mg)
100 mg
Pharmaceutical form:
Active: Imatinib mesilate 119.47 mg equivalent to imatinib 100mg Excipient: Crospovidone Gelatin Iron oxide red Iron oxide yellow Sodium laurilsulfate Sodium stearyl fumarate Tekprint red SB-1033 Titanium dioxide Water
Prescription type:
Manufactured by:
Hetero Labs Limited
Therapeutic indications:
Treatment of adult and paediatric patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukaemia (Ph+CML). Treatment of adult and paediatic patients with Ph+CML in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy.
Product summary:
Package - Contents - Shelf Life: Blister pack, PVC/ Aclar or Aluminium/Aluminium - 60 capsules - 24 months from date of manufacture stored at or below 25°C protect from moisture
Authorization number:
Authorization date:

Similar products

Search alerts related to this product

Share this information